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Abstract
Objective: The aim of the study was to discuss the results of catheter-directed thrombolysis and complementary
procedures to treat acute iliofemoral deep vein thrombosis (DVT) evaluating the safety and effectivness of an easy
access such as the Great Saphenous Vein.
Methods and materials: A total of 22 consecutive patients with iliofemoral thrombosis and two patients with
femoro-popliteal thrombosis on recent onset diagnosed with Ultrasound Doppler and contrast venography underwent
intrathrombus drip infusion of urokinase while intravenous heparin was continued using saphenical access. Residual
venous stenosis were treated in six patients by percutaneous balloon Angioplasty and stenting. All patients underwent
routine venous duplex imaging at 30 days, 3 months, 6 months and every 6 months thereafter.
Results: Complete patency of thrombosed veins was restored in 22 patients (91 %) with prompt symptomatic relief.
There were no major complications in the immediate outcomes. At follow-up, two patients reported a persistant slim
iliac vein stenosis, two patients had post-thrombotic syndrome, and two patients showed Deep Vein Reflux.
Conclusion: Local thrombolysis using saphenical access was a safe and effective approach for the treatment of acute
iliofemoral deep vein thrombosis. It seems to be a valid, easy and safe alternative, reducing the risks of haematoma and
venous lesions, which can be observed when using femoral, popliteal, and trans-jugular access.
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Introduction
Ilio-femoral deep vein thrombosis (DVT) treated with
conventional therapy have showed to severly compro-
mised muscle pump function and valvular competency at
5 years follow-up despite improvement in venous outflow
and only 6 % of patients with acute proximal DVT had
complete lysis of the thrombus within 10 days [1, 2]. In
the last years, loco-regional fibrinolytic therapy has
increasingly been used in the treatment of DVT af-
fecting inferior limbs, in response to the controversial
and negative results obtained altogether with surgical
venous thrombectomy in long-term follow-up studies
[3, 4]. Catheter-directed thrombolysis with angioplasty
and stenting when needed can be done using femoral,
jugular, pedal veins access [3, 5] but can result diffi-
cult for some patients such as politraumatic or neo-
plastic patients or patient who complicated after
surgery. The objective of this study was to see if
saphenous vein could be an alternative access for
locoregional thrombolysis in complicated patients.
We will describe the results obtained after 2 years
follow-up in 24 patients who underwent catheter-directed
thrombolysis using an original access such as the Great
Saphenous Vein (GSV).
The major advantages of this access is that it is a safer
procedure than deep venous system puncture and is easy
to perform even in day-hospital.
Methods and materials
We prospectively collected data of patients treated due
to DVT from October 2010 to November 2011. There
were 22 patients between 18 and 62 years of age affected
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by DVT of the iliac-femoral vein and two patients with
femoro-popliteal DVT of recent onset (≤14 days) ten of
which were of idiopathic origins, six were as a result of
Orthopaedic Surgery, four were polytraumatic patients
and two cases were due to an abnormality of the venous
system of the inferior caval vein and two were related
with neoplastic disease. Nine of the ten idiopathic cases
showed afterwards trombofilic factors and triggering fac-
tors such as the use of oral contraceptive pill. One pa-
tient showed a previous episode of pulmonary embolism
(PE) highlighted by Computer tomography scansion
(CT-scan). Patients with an onset of ilio-femoral venous
thrombosis of more than 14 days or with a history of
chronic DVT were excluded. The risk and benefit of
treatment were fully explained and informed consent
was obtained from all patients. All patients were symp-
tomatic at the time of presentation and all underwent
venous duplex imaging and phlebography to evaluate
the infra-inguinal deep venous system and the proximal
extend of the thrombus.
Our objectives were the recanalization of the vessels, the
prevention of pulmonary embolism and postphlebitic syn-
drome. Thus, we proceeded in Radiological Surgery room
under local anaesthesia with the positioning of a tempor-
ary IVC filter (ALN) in the patient with pregress PE below
the renal veins throught controlateral femoral percutan-
eous access. Local anaesthesia was done with 1 % lidocaine
and epinephrine and patients were positioned supine with
foot externally rotated with a tourniquet above the ankle
and the skin was prepared with antiseptic solution (beta-
dine) and the area was drape. Great saphenous vein (GSV)
was prepared surgically 1 cm superior to the medial malle-
olus with a 2.5 cm full-thickness transverse skin incision
over the site, subcutaneous tissue was dissected parallel to
the course of the saphenous vein. The vein was free from
its bed for 2 cm and with the curved haemostat,ties were
passed proximally and distally to the exposed vein.
Small transverse venotomy was performed with scalpel
no.11 blade and catheter was inserted. In two patients
treated for femoro-popliteal thrombosis we performed
the incannulation of a perforating vein. A 5Fr introduc-
tory was positioned and Angiodynamics Flus Catheter
Straight Sideholes was insert on guidedwire Terumo
angled type 0.035. Phlebography was then performed in
all patients and lytic agent was delivered. Urokinase
(Abbokinase; Abbott Laboratory, North Chicago, IL) was
infused (30–80 000UI/h) and Heparin (20–25.000UI/24 h)
was administrated concomitantly for 48–84 h. Twenty-
four to thirty-six hours later, the catheter was moved
through external iliac vein and lytic infusion was contin-
ued. Phlebography was performed before each procedure.
The procedure was repeated if necessary. After 48 h a re-
peat venogram showed partial resolution of the thrombus
and visualization of iliocaval axis in all patients. The mean
duration of the treatment was 2–5 days. Fibrinogen level
and aPTT were obtained before and every 12 h after
thrombolytic therapy. If fibrinogen level was less than
100 mg/dL then lytic therapy was stopped and additional
heparin was given. Prothrombin time, INR and hematocrit
levels were also performed for all patients. Venous Dup-
plex Scanning and phlebography were performed at 12, 24,
36 h intervals. Routine venous duplex imaging was per-
formed for all patients at 1, 3, 6, 12 and 24 months. For all
patients treatment continued with oral anticoagulant and
elastic compression stocking (monocollant postOp Gloria
Med Thrombosis 28–30 mmHg). Compression stockings
in patients with diagnosis of DVT should be applied within
1 month of diagnosis and continued for a minimum of
1 year after diagnosis to reduce the incidence of PTS [6, 7].
Results
It was observed in all the treated cases a partial lysis of the
femoral and iliac thrombus in the first 24 h. Valvular com-
petence was maintained in 20 patients (absence of reflux at
Valsava manoeuvre). After 48 h a repeat venogram showed
the complete resolution of the thrombus in 16 patients
with complete visualization of iliocaval axis. In the case of
one of the neoplastic patient we used a Castaneda
Thrombolytic Brush (MTI) and after 48 h of partial reso-
lution of the thrombus the patient underwent isteroanne-
sectomy surgery. Six patients showed remaining stenoses
that were successfully treated with PTA/stenting (Ghost II,
NuMED). Repeat venograms on those patients demon-
strated much better flow throught the veins and wide pa-
tency of the previous stenotic lesions (Table 1).
In the patient affected by PE, radiological procedure
showed the correct positioning of the endocaval filter.
Therapy was continued with oral anticoagulants and
medical compression stockings, and patients were main-
tained within INR values of 2 and 3. At 2-year follow-up
two patients had PTS (venous ulcer), two showed deep
vein reflux and all of them were supplied with compres-
sive stock. Two patients had still a slim stenosis of the
iliac vein that we didn’t treat (Table 2).
Discussion
Traditional treatment for DVT consists in routine antic-
oagulation therapy to prevent pulmonary embolism and
to avoid the propagation of thrombus. This way can be
considered as a “soft” approach and can be reserved to
those patients at high risk because of their age and/or
clinical conditions. However conventional anticoagula-
tion therapy depends solely on the effectiveness of the
patient’s fibrinolytic system but studies have showed that
only 6 % of patients with acute proximal DVT show
complete lysis of the thrombus within 10 days [1]. How-
ever anticoagulation alone does not prevent the effect of
thrombus on the leaflets of venous valves. Most patients
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with iliofemoral DVT have a substantial rate of acute com-
plications and severe post-thrombotic sequelae which are
associated with higher ambulatory venous pressure that
occurs in patients who have both venous obstruction and
valvular incompetence resulting in chronic venous insuffi-
ciency, pain, hyperpigmentation of the skin, chronic limb
oedema and venous ulceration with a rate from 2 to 28 %
[1–3, 8–10]. An “aggressive” approach is represented by a
loco-regional infusion of thrombolytic agents such as uro-
kinase, alteplase or reteplase (Rt-TPA).
Rt-TPA is a plasminogen activator and must be given
carefully in solution of 10 mg in 490 ml of 0.9 % NaCl at
the speed of 50 ml/h always in association with 2.500 UI
of heparin followed by 500 UI trough Intra venous access.
In the late 1998, alteplase has become the most commonly
used agent for catheter-directed thrombolysis [11]. The
aim of this procedure is to speed up vein recanalization to
avoid vein damages and DVT complications as post-
phlebitic syndrome. Semba and Dake report 95 % of
PTS in patients with iliac and caval thrombosis treated
just with anticoagulant therapy [12]. Approaches most
frequently used are the popliteal vein access, femoral
vein access and jugular access. The choice of the most
adequate way depends of both surgery attitude and
anatomy of the thrombi. It is possible to introduce a
IVC filter before thrombolysis obviously using the jugu-
lar access even if many studies failed to show symptom-
atic pulmonary embolism in patients that underwent
thrombolysis [3, 5, 13, 14] In the cases of ilio-femoral
DVT extending in distal popliteal vein, the popliteal ap-
proach is recommended using a 5F introductory mak-
ing lateral pores like a multipore catheter [8]. Popliteal
vein should be puncture under ultrasound control to
avoid popliteal arterial puncture risking arteriovenous
fistula or trauma to the deep veins. This does not hap-
pen when using great saphenical access. Some authors
have infuse lytic agent from a pedal vein but this technique
appears less effective and requires longer period [11]. Fem-
oral vein can also be used although retrograde placement
of the infusion catheter may result in injury to the valve
leaflets [11]. Venous blood obeys a single law, which is the
pressure gradient, and at rest in the middle of expiration
blood flow is maximal in the deep venous network via the
perforating veins from the superficial veins. When there is
an obstruction in the deep veins, the blood of the superfi-
cial network will be aspirated towards the patent deep ven-
ous trunk this is the reason why fibrinolysis will undergo
directly throught the deep venous system [15].
The greater saphenous vein is the longest vein in the hu-
man body and originates at the ankle as a continuation of
the medial marginal vein of the foot and ends at the fem-
oral vein within the femoral triangle. At the ankle, it
crosses 1 cm anterior to the medial malleolus and con-
tinues up the anteromedial aspect of the lower leg. It con-
tinues its superficial course and lies on the posteromedial
aspect at the level of the knee. In the thigh, the greater sa-
phenous vein courses anterolaterally through the fossa
ovalis where it joins the femoral vein approximately 4 cm
below the inguinal ligament. Saphenous access is also use
as an emergent venous access for anaesthetist in difficult
cases where other access has failed. Complications can be
failed cannulation, creation of a false passageway in the
vessel wall, haemorrhage, infection, nerve transection, all
complications avoiable with experience. Some Authors
used a double system with coaxial catheters (multiside-
holes and end-tip catheter) collegated at two different
pomp infusion [10]. Because venous collaterals develop in
venous occlusions, it is not usually possible to deliver the
Table 1 Patients characteristics and immediate outcomes
No. of patients 24
Age (y), 35
Mean range (18–62)
Location 20 (83 %) Left Side
4 (17 %) Right Side
Extention of DVT 22 (92 %) ilio-femoral
2 (8 %) femoro-popliteal
Causes Idiopathic 10 (42 %)
Orthopaedic Surgery 6 (25 %)
Politrauma 4 (17 %)
Venous anomaly 2 (8 %)
Neoplastic disease 2 (8 %)
Pregress PE 1(4 %)
Lytic Agent Used 24 (100 %) UK




Partial Lysis of thrombi after 24 h 24
Recanalization of GSV and
valvular continence
20
Complete Recanalization after 48 h 16
Table 2 Outcomes after 2 years follow-up
No. of patients 24
Reccurence 0
Persistant occlusoin or stenosis 2 (8 %)
Deep Vein Reflux 2 (8 %)
Medical stoking compression 20≤ 6 months
2≥ 6 months
2≥ 12 months
Anticoagulant therapy 4≥ 6 months
20≥ 6 months
PTS 2 (8 %) venous ulcer
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lytic agent directly to the thrombus when systematic infu-
sion is used, transcatheter infusion of lytic agent can de-
liver high concentrations directly into the thrombus while
minimizing the potential for a systematic fibrinolytic effect
[3, 5] The aim of the procedure was the complete early
opening of occluded veins and, trough sapheno-femoral
ostium carry on thrombolytic therapy for the complete
resolution of the thrombus. Scaring that thrombi age
vanify trombolitic therapy effect made us to be against a
partial outcome, sacrificing femoral vein in two patients.
As a result we observed a “retrograde effect” at the first
check, with progressive recanalization of the femoral vein.
Another positive prognostic element revealed during ther-
apy was the preservation of valve continence of the
sapheno-femoral junction in 20 patients.
The critic we move to ourselves is the fact that we
didn’t treat the slim stenosis of the iliac vein with a stent
in two patients. However the high percent of immediate
thrombosis after stenting in cases of elder age excuses
our prudency, also considering the long time fibrinolytic
therapy done [14, 16]. In all the cases we used urokinase,
but some recent studies showed that recombinant agents
like alteplase (tissue plasminogen activator [TPA]) and
reteplase (recombinant plasminogen activator [RPA]) are
significantly less expensive [12].
Conclusions
Even if no general consensus exist on the optimal treat-
ment for DVT [17], thrombolytic therapy is faster than
standard therapies such as heparin and warfarin and can
produce better results because the medication is direc-
tional to the clot permitting the resolution of the symp-
toms, preventing PTS and decreasing the risk of PE [18].
Catheter-directed thrombolysis is faster and can produce
better results as the medication is directional at the clot.
Remain proximal obstruction should be resolved with
stenting or bypass. Indeed, Bättler et al. demonstrated that
local thrombolysis, applied under ischemic conditions
combined with surgical thrombectomy is easy to perform,
vein patency and valve function are restored and post
thrombotic syndrome is prevented [19]. Selective place-
ment of IVC filter in patients at risk is a safe and appropri-
ate approach [20]. Several routes of local lytic therapy are
generally available such as the transjugular vein approach,
contralateral femoral vein puncture, ipsilateral femoral
vein puncture, ipsilateral popliteal vein puncture and infu-
sion into the foot vein [21]. Ipsilateral vein puncture is
most useful for thrombus extending from the inferior
vena cava into the superficial femoral vein, the transjugu-
lar approach can be difficult because of venous valves and
infusion into foot vein may be difficult as patients and
nursing staff need to maintain the catheter for 2 to 3 days
[3, 5, 10, 16, 18] Saphenous access can become an excel-
lent alternative when other approaches are unfeasible or
have failed [22]. Although the procedure can be per-
formed at multiple sites along the length of the saphenous
vein, it is commonly performed at the ankle because the
predictable and superficial location of the vein in this area
allows it to be exposed with minimal dissection. Despite
the short number of patients treated using the GSV as an
access, our study has proven that it is a valid, safe and easy
alternative to the traditional access for loco regional fi-
brinolytic therapy especially for the treatment of sapheno-
femoral axis and common femoral vein thrombosis.
Femoro-popliteal axis can also be reached introducing the
catheter in a perforating vein. Saphenical access is un-
problematic and well tolerated.
Moreover this approach may be a valid alternative to
reduce the risk of haematoma and venous lesions, which
can be observed when using femoral, popliteal, and trans
jugular access. In fact, our bleeding rate was lower than
bleeding rates reported in other studies [15, 19].
Our aim with this experience was to accelerated the
process of recanalization of the vein in the attempt to
save the valves and therefore to reduce to minimum the
risks of post-thrombotic syndrome, unavoidable sequel
of DVT.
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